SCHEMBL6112477

SCHEMBL6112477

CCc1n[nH]c(CCc2ccccc2)nc1=O

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALPL P05186 3/20 0.51
DAO P14920 3/20 0.49
SMN1; SMN2 Q16637 2/20 0.46
POLB P06746 1/20 0.46
MAPT P10636 1/20 0.46
ALDH1A1 P00352 1/20 0.44
PARP1 P09874 2/20 0.43
RAB9A P51151 3/20 0.42
CCNE2 O96020 1/20 0.41
CDK4 P11802 1/20 0.41
CCND1 P24385 1/20 0.41
CCNE1 P24864 1/20 0.41
CDK2 P24941 1/20 0.41
HTT P42858 2/20 0.41
QPCT Q16769 1/20 0.40
RNASEH1 O60930 1/20 0.40
NPC1 O15118 2/20 0.40
AR P10275 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7316537 0.78 PARP1 (0.46) ALPLDAOSMN1; SMN2POLBALDH1A1
SCHEMBL25249969 0.78 ALPL (0.54) ALPLDAOSMN1; SMN2POLBMAPT
SCHEMBL17279708 0.72 ALPL (0.53) ALPLDAOSMN1; SMN2POLBMAPT
SCHEMBL6004747 0.71 ALPL (0.46) ALPLDAOSMN1; SMN2POLBMAPT
SCHEMBL9790418 0.70 ALPL (0.51) ALPLDAOSMN1; SMN2POLBMAPT
SCHEMBL26111895 0.70 ALPL (0.51) ALPLDAOSMN1; SMN2POLBMAPT
SCHEMBL30939057 0.70 ALPL (0.44) ALPLDAOSMN1; SMN2POLBMAPT
SCHEMBL4718005 0.69 DAO (0.44) ALPLDAOSMN1; SMN2POLBMAPT
SCHEMBL7659167 0.68 PARP1 (0.46) ALPLDAOPOLBPARP1RAB9A
SCHEMBL17321269 0.66 RAB9A (0.49) DAOSMN1; SMN2MAPTALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006063811-A2 SUBSTITUTED 1,2,4-TRIAZIN-5(2H)-ONES BAYER HEALTHCARE AG (DE) 2006-06-22 WO disclosed
WO-2006063813-A2 3-ARYLALKYL-SUBSTITUTED AND 3-HETEROARYLALKYL-SUBSTITUTED-1,2,4-TRIAZIN-5(2H)-ONES BAYER HEALTHCARE AG (DE) 2006-06-22 WO disclosed